Cancer Family
Mesothelial Neoplasm
CI-CAN-00000028Explore in graph →
Non-malignant108 active trials4 approved drugs13 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000028Explore in graph →
Clinical trials
521 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01912547 | Thromboelastography During Surgery for Malignant Pleural Mesothelioma | unknown | — | 100 | Brigham and Women's HospitalOTHER | 1 | Jan 30, 2015 | clinicaltrials |
| NCT00513877 | Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 33 | Cancer Trials IrelandNETWORK | 4 | Dec 31, 2014 | clinicaltrials |
| Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients |
| completed |
| — |
| 121 |
| Istituto Clinico HumanitasOTHER |
| 1 |
| Dec 2, 2014 |
| clinicaltrials |
| NCT01279967 | A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma(ADAM) | unknown | Phase 2 | 70 | Barts & The London NHS TrustOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT00309946 | Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | completed | Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2014 | clinicaltrials |
| NCT00325494 | A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer | completed | Phase 1 | 24 | MorphotekINDUSTRY | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00392444 | Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00668499 | A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma | withdrawn | Phase 1 / Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00165516 | Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate | completed | Phase 2 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | completed | Phase 1 | 70 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00897247 | Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | completed | — | 494 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT01241682 | Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma(PMR-MM-002) | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00027703 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 106 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2014 | clinicaltrials |
| NCT02029105 | Serum Biomarkers in Diagnosis of Mesothelioma | completed | — | 230 | Eskisehir Osmangazi UniversityOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00024271 | Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00006231 | Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma | completed | Phase 3 | 44 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002465 | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00006216 | Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma | unknown | Phase 1 | — | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00030459 | Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | unknown | Phase 2 | — | British Thoracic SocietyOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00075699 | Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 3 | 840 | Medical Research CouncilOTHER_GOV | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01105390 | AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00002608 | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | completed | Phase 2 | 30 | Ottawa Regional Cancer CentreOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00821860 | Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma(MesoVATS) | completed | Phase 3 | 196 | Papworth Hospital NHS Foundation TrustOTHER_GOV | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00062283 | Alanosine in Treating Patients With Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00005636 | Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | completed | Phase 3 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00107432 | Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00006014 | SU5416 in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00003263 | Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 1 | 6 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT01569919 | A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma(SKOPOS) | unknown | Phase 2 | 26 | Wales Cancer Trials UnitOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT00039182 | Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00025207 | Gefitinib in Treating Patients With Malignant Mesothelioma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00028782 | EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer | terminated | N/A | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01719068 | Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos | unknown | — | 200 | British Columbia Cancer AgencyOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00003723 | S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | completed | Phase 2 | 57 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT01655888 | The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma | unknown | Phase 2 | 29 | Azienda Ospedaliera Universitaria SeneseOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT01649024 | A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma | unknown | Phase 2 | 29 | Azienda Ospedaliera Universitaria SeneseOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00004254 | Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00004920 | Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | completed | Phase 3 | 256 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jul 18, 2012 | clinicaltrials |
| NCT00227630 | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 59 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Jul 18, 2012 | clinicaltrials |
| NCT00787410 | An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma | completed | Phase 2 | 23 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT00030745 | Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung | completed | Phase 2 | 61 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT01353482 | A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma(MESO-02) | withdrawn | Phase 1 / Phase 2 | 0 | University College, LondonOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00020124 | Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00137826 | Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma | completed | Phase 2 | 37 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 26, 2011 | clinicaltrials |
| NCT00996385 | Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma | unknown | Phase 2 | 29 | Columbia UniversityOTHER | 1 | Oct 31, 2011 | clinicaltrials |
| NCT00407459 | Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma | completed | Phase 2 | 77 | Armando Santoro, MDOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT01343264 | Trimodality Therapy for Malignant Pleural Mesothelioma | unknown | — | 200 | HSK WiesbadenOTHER | 1 | Apr 28, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jan 30, 2015source: clinicaltrials